Double Voiding and Post-transplant UTI

Part of paid clinical trials in New York, New York.

Sponsor
Weill Medical College of Cornell University
Study ID
NCT05711446
Status
Recruiting

Conditions

  • Kidney Transplant; Complications
  • Urinary Tract Infections

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Double Voiding — OTHER
    Participant will be instructed to void twice.
  • Regular Voiding — OTHER
    Participant will void as usual

Study Details

Urinary tract infections (UTI) are common in kidney transplant recipients and are an important cause of illness and hospital admissions. Past studies have shown that about 1 out of 5 of newly transplanted patients develop UTI within their first 3 months of transplantation. Such UTIs increase the risk for blood stream infection and acute rejection of the kidney, Improvements in urinary voiding techniques may reduce the frequency of UTI. The purpose of this study is to evaluate the benefits of "double voiding" in kidney transplant recipients.

Key Dates

Start date
Apr 7, 2023
Status verified
May 2026
Primary completion
May 31, 2027
Completion
May 31, 2027

Study Design

Enrollment
438 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Experimental: Double Voiding
    The participant will be instructed to void twice.
  • Active Comparator: Regular Voiding
    The participant will be instructed to void normally.

Primary Outcome Measure

Number of UTI's [ Time Frame: First 3 months of transplantation ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Weill Cornell Medical College / NY PresbyterianNew YorkNew York10065
Thangamani Muthukumar, M.D.
212-746-9074
Ananda Kimm-Drapeau
212-746-6137
Thangamani Muthukumar, M.D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in New York, NY

Related Studies